JP2007533705A5 - - Google Patents

Download PDF

Info

Publication number
JP2007533705A5
JP2007533705A5 JP2007508904A JP2007508904A JP2007533705A5 JP 2007533705 A5 JP2007533705 A5 JP 2007533705A5 JP 2007508904 A JP2007508904 A JP 2007508904A JP 2007508904 A JP2007508904 A JP 2007508904A JP 2007533705 A5 JP2007533705 A5 JP 2007533705A5
Authority
JP
Japan
Prior art keywords
mirtazapine
solid
preparation
pharmaceutical
solid form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007508904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533705A (ja
JP5260959B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/051714 external-priority patent/WO2005102352A1/en
Publication of JP2007533705A publication Critical patent/JP2007533705A/ja
Publication of JP2007533705A5 publication Critical patent/JP2007533705A5/ja
Application granted granted Critical
Publication of JP5260959B2 publication Critical patent/JP5260959B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007508904A 2004-04-21 2005-04-19 ミルタザピンの塩を含む医薬組成物 Expired - Fee Related JP5260959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04101664.3 2004-04-21
EP04101664 2004-04-21
PCT/EP2005/051714 WO2005102352A1 (en) 2004-04-21 2005-04-19 Pharmaceutical composition comprising a salt of mirtazapine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013046645A Division JP2013136626A (ja) 2004-04-21 2013-03-08 ミルタザピンの塩を含む医薬組成物

Publications (3)

Publication Number Publication Date
JP2007533705A JP2007533705A (ja) 2007-11-22
JP2007533705A5 true JP2007533705A5 (enExample) 2008-06-05
JP5260959B2 JP5260959B2 (ja) 2013-08-14

Family

ID=34928990

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007508904A Expired - Fee Related JP5260959B2 (ja) 2004-04-21 2005-04-19 ミルタザピンの塩を含む医薬組成物
JP2013046645A Pending JP2013136626A (ja) 2004-04-21 2013-03-08 ミルタザピンの塩を含む医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013046645A Pending JP2013136626A (ja) 2004-04-21 2013-03-08 ミルタザピンの塩を含む医薬組成物

Country Status (31)

Country Link
US (1) US20070111993A1 (enExample)
EP (1) EP1729777B1 (enExample)
JP (2) JP5260959B2 (enExample)
CN (2) CN1942191B (enExample)
AR (1) AR049028A1 (enExample)
AT (1) ATE424210T1 (enExample)
AU (1) AU2005235383B2 (enExample)
BR (1) BRPI0509953A (enExample)
CA (1) CA2561281C (enExample)
CY (1) CY1109018T1 (enExample)
DE (1) DE602005013066D1 (enExample)
DK (1) DK1729777T3 (enExample)
EC (1) ECSP066938A (enExample)
ES (1) ES2321961T3 (enExample)
HR (1) HRP20090190T1 (enExample)
IL (1) IL178201A (enExample)
LV (1) LV13556B (enExample)
MX (1) MXPA06011830A (enExample)
MY (1) MY144899A (enExample)
NO (1) NO20065077L (enExample)
NZ (1) NZ550052A (enExample)
PE (1) PE20060400A1 (enExample)
PL (1) PL1729777T3 (enExample)
PT (1) PT1729777E (enExample)
RS (1) RS50764B (enExample)
RU (1) RU2375362C2 (enExample)
SI (1) SI1729777T1 (enExample)
TW (1) TW200538100A (enExample)
UA (1) UA89773C2 (enExample)
WO (1) WO2005102352A1 (enExample)
ZA (1) ZA200608305B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) * 1976-07-27 1980-03-18 Fiber Materials, Inc. Method of forming carbon composites
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
ES2212550T3 (es) * 1998-04-02 2004-07-16 Akzo Nobel N.V. Solucion oral liquida que comprende el antidepresor mirtazapina.
WO2001000196A2 (en) * 1999-06-25 2001-01-04 University Of South Florida Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
HK1047547B (en) * 2000-04-05 2003-10-10 Akzo Nobel N.V. Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug

Similar Documents

Publication Publication Date Title
IL259851A (en) Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders
HRP20161657T1 (hr) Kinazolinoni kao inhibitori humane fosfatidilinozitol 3- kinaze delta
JP2008501025A5 (enExample)
JP2010529118A5 (enExample)
FI2049506T4 (fi) Lääkkeellisten aineiden farmakokineettisten ominaisuuksien modulaattorit
WO2014078778A3 (en) Antiviral azasugar-containing nucleosides
FI2498756T4 (fi) Neratinibimaleaatin tablettiformulaatiot
GEP20125566B (en) Aryl-and heteroaryl-substituded tetrahydro-benzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
JP2009506117A5 (enExample)
JP2010513478A5 (enExample)
WO2007087431A3 (en) Sublingual fentanyl spray
WO2008087560A9 (en) Thiazolidine derivatives and methods for the preparation thereof
WO2007048066A3 (en) Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
WO2008020040A3 (en) 2,5-dihydroxybenzene compounds for the treatment of fibrosis
NO20091501L (no) Farmasoytiske sammensetninger
SE0104341D0 (sv) New use
JP2009538861A5 (enExample)
IL188643A (en) Derivatives – n (troaryl) –1 – troarylalkyl – 1h – indole – 2– carboxamide, process for the production of derivatives, drug, pharmaceutical composition and use of derivatives for drug production.
JP2009537554A5 (enExample)
BRPI0910758A2 (pt) composição sólida termoestável, composição farmacêutica, processos para a preparação de uma composição sólida termoestável e de uma composição farmacêutica, método para melhorar a biodisponibilidade de um ingrediente farmaceuticamente ativo, e, produto
WO2008006795A3 (en) Indole compounds
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
JP2005522432A5 (enExample)
JP2007523135A5 (enExample)
WO2023178111A3 (en) Organic compounds